A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

NCT01055834 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Eszopiclone 3 mg
DRUG: Eszopiclone 1 mg

Sponsor

Eisai Co., Ltd.